LifeVantage Co. (NASDAQ:LFVN) Short Interest Up 8.9% in December

LifeVantage Co. (NASDAQ:LFVNGet Rating) was the recipient of a large increase in short interest during the month of December. As of December 30th, there was short interest totalling 44,100 shares, an increase of 8.9% from the December 15th total of 40,500 shares. Based on an average daily volume of 30,800 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.4% of the shares of the company are sold short.

Institutional Investors Weigh In On LifeVantage

Hedge funds have recently made changes to their positions in the company. Renaissance Technologies LLC increased its position in shares of LifeVantage by 0.3% during the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company’s stock worth $4,238,000 after purchasing an additional 3,300 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of LifeVantage by 4.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock worth $1,293,000 after purchasing an additional 11,964 shares in the last quarter. BlackRock Inc. increased its position in shares of LifeVantage by 10.5% during the 1st quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock worth $1,188,000 after purchasing an additional 23,788 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of LifeVantage during the 1st quarter worth about $234,000. Finally, State Street Corp increased its position in shares of LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after purchasing an additional 3,281 shares in the last quarter. Institutional investors and hedge funds own 29.69% of the company’s stock.

LifeVantage Stock Performance

Shares of LFVN stock opened at $3.81 on Monday. LifeVantage has a 52-week low of $3.46 and a 52-week high of $6.68. The stock has a market cap of $47.89 million, a price-to-earnings ratio of 95.25 and a beta of 1.10. The firm has a fifty day moving average of $3.80 and a 200-day moving average of $3.90.

LifeVantage (NASDAQ:LFVNGet Rating) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported $0.06 earnings per share (EPS) for the quarter. LifeVantage had a net margin of 0.20% and a return on equity of 9.48%. The company had revenue of $51.77 million during the quarter. On average, sell-side analysts predict that LifeVantage will post 0.33 earnings per share for the current year.

LifeVantage Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 15th. Investors of record on Thursday, December 1st were given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 3.15%. The ex-dividend date of this dividend was Wednesday, November 30th. LifeVantage’s dividend payout ratio (DPR) is currently 300.00%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of LifeVantage in a research note on Tuesday, January 17th. They issued a “strong-buy” rating for the company.

LifeVantage Company Profile

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.

See Also

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.